yup, and each one has to be verified at one level or another. I also noticed that they are requiring some type of photographic documentation of the tumor which brings medical imaging into the fold as well. So we're probably talking imaging appointments like MRI and what not. These people are already dealing with a terrible disease so add in consultations with their current physicians and their busy schedules. Then coordinate all of this out of an office that appears to have recently lost a key staffer. Compound all of this and I think its likely slow the process of randomizing patients. None of if seems like a big deal but it adds up and takes time and diligence. Think about your last ER visit with all of the waiting and inefficiency and the explode it on a massive scale. That's my limited understanding of clinical trials.
Market Data 
Markets 
AI
